Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)

SHA:688336 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	196.54	193.27	459.49	933.26	1,091	1,614
Short-Term Investments	-	4,488	863.59	344.19	-	-
Trading Asset Securities	712.93	1,074	910.54	603.87	1,486	752.05
Cash & Short-Term Investments	909.47	5,755	2,234	1,881	2,577	2,366
Cash Growth	-47.24%	157.63%	18.73%	-27.00%	8.93%	-14.31%
Accounts Receivable	454.31	153.84	147.14	133.24	149.35	256.97
Other Receivables	0.5	0.16	0.03	0.2	0.29	0.53
Receivables	454.81	154	147.17	133.44	149.65	257.5
Inventory	285.5	260.55	229.6	194.96	227	210.14
Other Current Assets	4,632	60.21	49.64	40.09	32.54	38.09
Total Current Assets	6,282	6,229	2,660	2,250	2,986	2,872
Property, Plant & Equipment	1,565	1,534	1,539	1,562	1,426	1,371
Long-Term Investments	86.32	442.73	1,140	1,020	109.4	122.37
Goodwill	0.64	0.64	0.64	0.64	0.64	0.64
Other Intangible Assets	365.02	208.75	223.96	240.16	195.73	196.55
Long-Term Deferred Tax Assets	126.38	125.98	129.62	145.74	173.43	155.31
Long-Term Deferred Charges	208.55	341.94	228.54	44.44	114.02	97.67
Other Long-Term Assets	399.73	74.35	43.68	42.16	92.76	73.59
Total Assets	9,033	8,957	5,965	5,305	5,098	4,889

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	69.6	34.96	34.96	21.93	15.91	16.27
Accrued Expenses	42.03	172.13	174.93	181.2	56.18	127.71
Short-Term Debt	-	-	50.02	50.03	150.1	-
Current Income Taxes Payable	9.85	141.29	-	1.3	1.2	0.21
Current Unearned Revenue	29.79	62.1	20.2	16.77	19.55	3.25
Other Current Liabilities	163.43	36.54	36.8	36.91	132.15	68.01
Total Current Liabilities	314.69	447.02	316.91	308.14	375.09	215.45
Long-Term Unearned Revenue	85.9	95.6	111.24	118.33	123.79	134.28
Total Liabilities	400.59	542.62	428.15	426.47	498.88	349.73

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	896.26	618.09	616.79	616.79	616.79	616.21
Additional Paid-In Capital	2,105	2,386	2,310	2,303	2,309	2,301
Retained Earnings	5,733	5,462	2,639	1,985	1,691	1,641
Comprehensive Income & Other	-58.59	-13.58	2.44	-8.71	-10.67	-17.33
Total Common Equity	8,676	8,453	5,568	4,896	4,606	4,542
Minority Interest	-42.83	-38.21	-30.76	-17.58	-6.32	-2.46
Shareholders' Equity	8,633	8,415	5,537	4,879	4,600	4,539
Total Liabilities & Equity	9,033	8,957	5,965	5,305	5,098	4,889

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	50.02	50.03	150.1	-
Net Cash (Debt)	909.47	5,755	2,184	1,831	2,427	2,366
Net Cash Growth	-47.24%	163.53%	19.24%	-24.55%	2.59%	-14.31%
Net Cash Per Share	1.02	6.41	2.44	2.06	2.72	2.71
Filing Date Shares Outstanding	858.95	896.23	894.34	894.34	894.34	893.51
Total Common Shares Outstanding	858.95	896.23	894.34	894.34	894.34	893.51
Working Capital	5,967	5,782	2,343	1,942	2,611	2,656
Book Value Per Share	10.10	9.43	6.23	5.47	5.15	5.08
Tangible Book Value	8,310	8,244	5,343	4,655	4,409	4,344
Tangible Book Value Per Share	9.67	9.20	5.97	5.21	4.93	4.86
Buildings	-	818.98	626.77	626.77	531.48	531.48
Machinery	-	1,333	1,220	1,196	1,043	1,035
Construction In Progress	-	544.11	749.65	687.81	717.11	572.47

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error